Twelve metabolites of the synthetic cannabinoid, EAM-2201, have been tentatively recognized in human hepatocytes in vitro, and in human liver and urine specimens in vivo for the first time. For that reason, we conclude that fitting only to sound period Qualities, as is done in the majority of opportunity development techniques, generally isn't s